Reaction Details Report a problem with these data
Target
IgG receptor FcRn large subunit p51
Ligand
BDBM50270817
Substrate
n/a
Meas. Tech.
ChEMBL_552584 (CHEMBL956456)
IC50
2000±n/a nM
Citation
 Mezo, AR; McDonnell, KA; Castro, A; Fraley, C Structure-activity relationships of a peptide inhibitor of the human FcRn:human IgG interaction. Bioorg Med Chem 16:6394-405 (2008) [PubMed]  Article 
Target
Name:
IgG receptor FcRn large subunit p51
Synonyms:
FCGRN_HUMAN | FCGRT | FCRN
Type:
PROTEIN
Mol. Mass.:
39742.86
Organism:
Homo sapiens (Human)
Description:
ChEMBL_627631
Residue:
365
Sequence:
MGVPRPQPWALGLLLFLLPGSLGAESHLSLLYHLTAVSSPAPGTPAFWVSGWLGPQQYLSYNSLRGEAEPCGAWVWENQVSWYWEKETTDLRIKEKLFLEAFKALGGKGPYTLQGLLGCELGPDNTSVPTAKFALNGEEFMNFDLKQGTWGGDWPEALAISQRWQQQDKAANKELTFLLFSCPHRLREHLERGRGNLEWKEPPSMRLKARPSSPGFSVLTCSAFSFYPPELQLRFLRNGLAAGTGQGDFGPNSDGSFHASSSLTVKSGDEHHYCCIVQHAGLAQPLRVELESPAKSSVLVVGIVIGVLLLTAAAVGGALLWRRMRSGLPAPWISLRGDDTGVLLPTPGEAQDADLKDVNVIPATA
  
Inhibitor
Name:
BDBM50270817
Synonyms:
CHEMBL524659
Type:
Small organic molecule
Emp. Form.:
C86H124N24O22S2
Mol. Mass.:
1910.182
SMILES:
CC(C)C[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCC(N)=O)C(C)(C)S)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O)C(C)(C)S |r,wU:88.90,103.108,126.132,71.74,27.35,49.59,4.4,41.43,111.115,82.86,wD:60.70,16.24,45.47,107.111,(33.06,-30.98,;33.06,-32.53,;34.4,-33.29,;31.73,-33.29,;31.73,-34.83,;30.39,-35.6,;29.06,-34.83,;29.06,-33.28,;27.73,-35.6,;26.4,-34.83,;25.07,-35.61,;25.07,-37.15,;23.73,-34.84,;22.4,-35.61,;21.06,-34.84,;21.06,-33.29,;19.73,-35.61,;19.73,-37.15,;21.06,-37.92,;22.39,-37.15,;23.72,-37.92,;23.73,-39.46,;22.4,-40.23,;21.06,-39.47,;18.4,-34.84,;17.07,-35.62,;17.07,-37.16,;15.74,-34.85,;15.74,-33.31,;17.07,-32.54,;18.48,-33.17,;19.51,-32.02,;18.73,-30.69,;17.23,-31.01,;14.39,-35.6,;13.05,-34.84,;13.05,-33.29,;11.72,-35.61,;10.39,-34.84,;9.05,-35.61,;9.05,-37.14,;7.72,-34.83,;6.38,-35.61,;5.05,-34.83,;5.05,-33.29,;3.72,-35.61,;2.39,-34.84,;1.06,-35.62,;1.06,-37.16,;-.28,-34.85,;-.28,-33.3,;1.06,-32.54,;2.4,-33.31,;3.73,-32.54,;3.73,-30.99,;2.38,-30.23,;1.06,-31.01,;-1.62,-35.61,;-2.95,-34.84,;-2.95,-33.3,;-4.28,-35.62,;-4.28,-37.15,;-2.95,-37.92,;-2.95,-39.46,;-1.61,-40.22,;-1.6,-41.76,;-2.95,-42.53,;-.28,-42.53,;-5.6,-34.83,;-6.92,-35.63,;-6.92,-37.17,;-8.25,-34.86,;-9.6,-35.6,;-8.25,-33.31,;-6.92,-32.55,;-6.92,-31.01,;-8.25,-30.24,;-5.58,-30.24,;3.72,-37.14,;5.27,-37.15,;2.18,-37.13,;3.72,-38.69,;7.72,-33.29,;6.39,-32.53,;9.05,-32.52,;33.06,-35.61,;33.06,-37.14,;34.4,-34.83,;35.72,-35.61,;37.06,-34.83,;37.06,-33.29,;35.73,-32.53,;35.73,-30.99,;37.06,-30.22,;37.06,-28.67,;38.4,-30.98,;38.41,-32.51,;35.72,-37.14,;34.4,-37.92,;37.06,-37.92,;38.63,-37.39,;39.66,-38.72,;38.71,-40.1,;37.31,-39.42,;36.08,-40.35,;34.66,-39.74,;36.26,-41.88,;35.04,-42.81,;35.22,-44.34,;36.63,-44.94,;33.98,-45.25,;34.17,-46.78,;35.59,-47.39,;35.77,-48.91,;34.54,-49.82,;37.19,-49.52,;32.94,-47.7,;31.52,-47.1,;33.12,-49.23,;31.89,-50.15,;32.08,-51.68,;33.5,-52.28,;30.85,-52.61,;30.74,-54.29,;29.12,-54.72,;28.21,-53.3,;29.38,-52.28,;29,-50.79,;27.51,-50.39,;30.08,-49.7,;33.62,-42.21,;34.13,-40.75,;33.13,-43.67,;32.12,-41.8,)|
Structure:
Search PDB for entries with ligand similarity: